Xin-lan Luo

445 total citations
35 papers, 334 citations indexed

About

Xin-lan Luo is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Xin-lan Luo has authored 35 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 12 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Xin-lan Luo's work include Lymphoma Diagnosis and Treatment (16 papers), HER2/EGFR in Cancer Research (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Xin-lan Luo is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), HER2/EGFR in Cancer Research (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Xin-lan Luo collaborates with scholars based in China, Germany and United States. Xin-lan Luo's co-authors include Donglan Luo, Yan‐Hui Liu, Fangping Xu, Li‐Xu Yan, Jie Xu, Fen Zhang, Xiaolan Zhu, Ping Mei, Chao Liu and Jie Chen and has published in prestigious journals such as PLoS ONE, Breast Cancer Research and Treatment and American Journal of Clinical Pathology.

In The Last Decade

Xin-lan Luo

33 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xin-lan Luo China	9	131	130	105	92	49	35	334
Zuguang Xia China	10	97 0.7×	160 1.2×	116 1.1×	87 0.9×	40 0.8×	33	314
Jessica Lam United States	7	203 1.5×	105 0.8×	91 0.9×	129 1.4×	40 0.8×	7	379
Erell Guillerm France	9	114 0.9×	102 0.8×	92 0.9×	153 1.7×	82 1.7×	21	351
Julia Ellermann Germany	3	119 0.9×	60 0.5×	55 0.5×	70 0.8×	28 0.6×	3	251
Borgny Ytterhus Norway	11	192 1.5×	178 1.4×	57 0.5×	125 1.4×	23 0.5×	23	370
Vinciane Marchand France	9	59 0.5×	106 0.8×	164 1.6×	70 0.8×	85 1.7×	13	257
André Uchimura Bastos Brazil	12	236 1.8×	105 0.8×	59 0.6×	135 1.5×	28 0.6×	17	494
A. Valent France	10	101 0.8×	155 1.2×	52 0.5×	89 1.0×	33 0.7×	18	318
Mélissa Alame France	9	233 1.8×	100 0.8×	93 0.9×	51 0.6×	31 0.6×	15	402

Countries citing papers authored by Xin-lan Luo

Since Specialization

Citations

This map shows the geographic impact of Xin-lan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin-lan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin-lan Luo more than expected).

Fields of papers citing papers by Xin-lan Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin-lan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin-lan Luo. The network helps show where Xin-lan Luo may publish in the future.

Co-authorship network of co-authors of Xin-lan Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xin-lan Luo. A scholar is included among the top collaborators of Xin-lan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin-lan Luo. Xin-lan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yao, Su, Fen Zhang, Yu Chen, et al.. (2022). Fbw7 Inhibits the Progression of Activated B-Cell Like Diffuse Large B-Cell Lymphoma by Targeting the Positive Feedback Loop of the LDHA/lactate/miR-223 Axis. Frontiers in Oncology. 12. 842356–842356. 10 indexed citations

Xu, Fangping, Kun Wang, Jie Xu, et al.. (2017). Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines. Breast Cancer Research and Treatment. 166(3). 757–764. 6 indexed citations

Wu, Hongmei, Fen Zhang, Yu Chen, et al.. (2017). Myxoid Adrenocortical Adenoma: A report of two cases and literature review. Pathology - Research and Practice. 213(7). 857–859. 1 indexed citations

Yao, Su, Fangping Xu, Yu Chen, et al.. (2017). Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation. Journal of Experimental & Clinical Cancer Research. 36(1). 10–10. 25 indexed citations

Yan, Jinhai, Donglan Luo, Fen Zhang, et al.. (2017). Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour. Histopathology. 71(6). 951–959. 18 indexed citations

Yan, Jinhai, Fen Zhang, Donglan Luo, et al.. (2017). Intravascular NK/T-cell lymphoma: a series of four cases.. PubMed. 10(9). 9541–9550. 9 indexed citations

Yan, Li‐Xu, Yan‐Hui Liu, Jianwen Xiang, et al.. (2015). PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. International Journal of Oncology. 48(2). 471–484. 97 indexed citations

Zhang, Fen, Xin-lan Luo, Yú Chen, & Yan‐Hui Liu. (2015). Intravascular large B-cell lymphoma involving gastrointestinal stromal tumor: a case report and literature review. Diagnostic Pathology. 10(1). 214–214. 6 indexed citations

Yan, Li‐Xu, Yan‐Hui Liu, Donglan Luo, et al.. (2014). MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified. PLoS ONE. 9(8). e104068–e104068. 65 indexed citations

10.

Luo, Donglan, Yan‐Hui Liu, Fen Zhang, et al.. (2013). [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].. PubMed. 42(9). 584–8. 3 indexed citations

11.

Xu, Fangping, Yan‐Hui Liu, Donglan Luo, et al.. (2011). [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].. PubMed. 40(9). 616–21. 3 indexed citations

12.

Luo, Donglan, Yan‐Hui Liu, Li Li, et al.. (2011). [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].. PubMed. 40(4). 235–9. 3 indexed citations

13.

Wu, Hongmei, Yan‐Hui Liu, Lin Feng, et al.. (2011). [Association of HER2 protein expression with clinicopathologic features and prognosis in Chinese patients with gastric carcinoma].. PubMed. 40(5). 296–9. 10 indexed citations

14.

Liu, Yan‐Hui, Fangping Xu, Ning Liao, et al.. (2010). Efficacy of intraoperative GeneSearch Breast Lymph Node (BLN) Assay for breast cancer metastasis detection in sentinel lymph node in Chinese patients. Cancer Science. 101(8). 1920–1924. 7 indexed citations

15.

Liu, Yan‐Hui, Fangping Xu, Jianyu Rao, et al.. (2009). Justification of the Change From 10% to 30% for the Immunohistochemical HER2 Scoring Criterion in Breast Cancer. American Journal of Clinical Pathology. 132(1). 74–79. 18 indexed citations

16.

Zhang, Fen, et al.. (2009). [Perivascular epithelial cell tumor of urinary bladder].. PubMed. 38(2). 131–2. 1 indexed citations

17.

Li, Min, Liu Yanhui, Xiaobing Wang, et al.. (2009). [Analysis of diagnosis accuracy of frozen sections in 73 cases of borderline tumor of ovary].. PubMed. 38(2). 106–9. 4 indexed citations

18.

Li, Li, et al.. (2007). [Gene expression profiling of diffuse large B-cell lymphoma in China].. PubMed. 36(2). 79–83.

19.

Liao, Ri-Qiang, et al.. (2006). [RRM1 expression in tissue microarray and prognosis analysis in non-small cell lung cancer].. PubMed. 9(5). 423–7. 1 indexed citations

20.

Liu, Yanhui, et al.. (2002). Diagnosis and differential diagnosis of nodular lymphocyte-predominant Hodgkin's lymphoma.. PubMed. 31(3). 227–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact